Trial intelligence / Profile preview

Kanglaite Injection for Cancer Cachexia

NCT02553187Phase 4Unknown

Sponsor
Zhejiang Kanglaite Pharmaceutical Co., Ltd.
Start
Sep 2015
Primary completion
Jul 2017
Modality
HM (Herbal Medicine)
Countries
1
01

Overview

A Phase 4 trial of kanglaite in cancer cachexia, sponsored by Zhejiang Kanglaite Pharmaceutical Co., Ltd.. Status: unknown.

02

Drugs

kanglaite
03

Conditions

cancer cachexia

Beyond the preview

Go deeper on NCT02553187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02553187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call